Rank |
Score |
Grant Number |
PI Name |
Project Title |
1 |
26 |
5R01DA011809-03 |
MACKLER, SCOTT |
NAC-1, A COCAINE-REGULATED MRNA IN THE RAT BRAIN |
2 |
26 |
3R01DA011809-03S1 |
MACKLER, SCOTT |
NAC-1, A COCAINE-REGULATED MRNA IN THE RAT BRAIN |
3 |
26 |
5R01DA008379-07 |
REITH, MAARTEN |
DOPAMINE TRANSPORTER AND COCAINE |
4 |
21 |
5R29DA010933-04 |
JACKSON, DENISE |
NEUROCHEMICAL EFFECTS OF PRENATAL COCAINE IN RAT STRIATA |
5 |
21 |
1R01DA013283-01A1 |
JOHNS, JOSEPHINE |
COCAINE & MATERNAL AGGRESSION--OXYTOCINERGIC MECHANISMS |
6 |
16 |
5R01DA011530-04 |
CARROLL, FRANK |
NOVEL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE |
7 |
16 |
2R01DA008590-08A1 |
JANDA, KIM |
Immunopharmacotherapy for the Treatment of Cocaine Abuse |
8 |
16 |
5R01DA013362-02 |
JOHNS, JOSEPHINE |
COCAINE AND MATERNAL NEGLECT: INTERGENERATIONAL EFFECTS |
9 |
16 |
5F32DA005935-03 |
KIMMEL, HEATHER |
COCAINE INDUCED CHANGES IN THE DOPAMINE TRANSPORTER |
10 |
16 |
5K01DA000384-04 |
MANDEVILLE, JOSEPH |
FMRI STUDY OF CNS PHYSIOLOGY DURING COCAINE RESPONSE |
11 |
16 |
1Z01DK059501-15 |
RICE, KENNER |
Design And Synthesis Of Drugs Acting On Central And Peri |
12 |
16 |
1R01DA012719-01A2 |
SNOW, DIANE |
Maternal Cocaine Use and Neurite Outgrowth |
|
|
|
|
|
13 |
16 |
3S06GM008016-30S20098 |
SOBRIAN, SONYA |
NEUROBEHAVIORAL EFFECTS OF PRENATAL COCAINE AND NICOTINE EXPOSURE |
14 |
16 |
3S06GM008016-30S30098 |
SOBRIAN, SONYA |
NEUROBEHAVIORAL EFFECTS OF PRENATAL COCAINE AND NICOTINE EXPOSURE |
15 |
16 |
5S06GM008016-310098 |
SOBRIAN, SONYA |
NEUROBEHAVIORAL EFFECTS OF PRENATAL COCAINE AND NICOTINE EXPOSURE |
16 |
16 |
5R01DA009161-06 |
WINGER, GAIL |
STIMULANTS, DEPRESSANTS & HALLUCINOGENS AS REINFORCERS |
17 |
16 |
3R01DA009161-06S1 |
WINGER, GAIL |
STIMULANTS, DEPRESSANTS & HALLUCINOGENS AS REINFORCERS |
18 |
16 |
1R01HL067745-01 |
ZHANG, LUBO |
Cocaine and Apoptosis in the Developing Heart |
19 |
11 |
1F32DK059723-01 |
AJA, SUSAN |
Central CART Peptide and Serotonin in Feeding Behavior |
20 |
11 |
5R21DA013830-02 |
AMARA, SUSAN |
EXPRESSION PROFILING OF PSYCHOSTIMULANT-REGULATED GENES |
21 |
11 |
5R01DA007741-05 |
BATTAGLIA, GEORGE |
SSRI TREATMENT OF PRENATAL COCAINE-INDUCED 5HT DEFICITS |
22 |
11 |
3S06GM008016-30S20073 |
COLEMAN, BERNELL |
EFFECTS OF CHRONIC ETHANOL INGESTION ON CARDIAC ACTIONS OF ETHANOL AND
COCAINE |
23 |
11 |
3S06GM008016-30S30073 |
COLEMAN, BERNELL |
EFFECTS OF CHRONIC ETHANOL INGESTION ON CARDIAC ACTIONS OF ETHANOL AND
COCAINE |
24 |
11 |
5S06GM008016-310073 |
COLEMAN, BERNELL |
EFFECTS OF CHRONIC ETHANOL INGESTION ON CARDIAC ACTIONS OF ETHANOL AND
COCAINE |
|
|
|
|
|
25 |
11 |
5K01DA000414-02 |
DAUNAIS, JAMES |
OPIOD - DOPAMINE INTERACTIONS IN COCAINE ABUSE |
26 |
11 |
5K05DA000119-14 |
DEADWYLER, SAMUEL |
HIPPOCAMPUS CORRELATES OF DRUG ABUSE IN RATS |
27 |
11 |
5P01DA008227-100010 |
DUMAN, RONALD |
NEUROPEPTIDE RECEPTORS AND DRUGS OF ABUSE |
28 |
11 |
1R01DA014684-01 |
GALLI, AURELIO |
Molecular mechanisms of stimulant abuse |
29 |
11 |
5R01DA011697-02 |
GNEGY, MARGARET |
PHARMACOLOGY OF DOPAMINE RELEASE BY AMPHETAMINE |
30 |
11 |
5R01DA009815-06 |
GRIGSON, PATRICIA |
DRUGS OF ABUSE AND LEARNED AVERSIONS: SOLVING A PARADOX |
31 |
11 |
5R01DA012473-02 |
GRIGSON, PATRICIA |
DRUGS OF ABUSE, REWARD COMPARISON, AND THE THALAMUS |
32 |
11 |
5P01DA009467-080004 |
JENKINS, BRUCE |
Synaptic Mechanisms of Dopaminergically Mediated MRI Signal Changes |
33 |
11 |
5K05DA000099-18 |
KORNETSKY, CONAN |
BRAIN STIMULATION MODELS OF DRUG ABUSE |
34 |
11 |
1R21DA014184-01 |
KORNETSKY, CONAN |
DRUGS OF ABUSE AND BRAIN STIMULATION REWARD IN THE MOUSE |
35 |
11 |
5R01DA010458-06 |
KOZIKOWSKI, ALAN |
CHEMICAL AND PHARMACOLOGICAL STUDIES OF COCAINE ANALOGS |
36 |
11 |
5R01DA012624-02 |
LIPTON, JACK |
OXIDANT STRESS AND COCAINE-INDUCED BRAIN INJURY IN UTERO |
37 |
11 |
5R29DA011665-04 |
MALDONADO-VLAAR, CARMEN |
NEURAL AND MOLECULAR MECHANISMS IN STRIATAL LEARNING |
38 |
11 |
1R01DA013189-01A1 |
MEANEY, MICHAEL |
Individual Differences in Mesolimbic Dopamine Systems |
39 |
11 |
1R01DA013661-01 |
MICHAEL, ADRIAN |
EXTRACELLULAR NEUROCHEMISTRY AND SUBSTANCE ABUSE |
40 |
11 |
1F31DA006098-01 |
MITCHELL, ELLEN |
MECHANISMS OF PRENATAL COCAINE AND ETHANOL TOXICITY |
|
|
|
|
|
41 |
11 |
5R29DA011004-04 |
PARSONS, LOREN |
COCAINE REWARD AND 5 HT 1B RECEPTORS--NEURAL MECHANISMS |
42 |
11 |
5R01DA012653-03 |
PIOMELLI, DANIELE |
CONTROL OF ENDOCANNABINOID RELEASE IN VIVO |
43 |
11 |
1R01DA012925-01A2 |
ROBERTS, DAVID |
GABA Modulation of Cocaine & Heroin Self-Administration |
44 |
11 |
1F31DA014161-01 |
ROTH, MEGAN |
Effects of Sex and Estrogen on Drug Self-Administration |
45 |
11 |
1Z01DA000121-11 |
ROTHMAN, RICHARD |
Structure/Function Of Opioid Receptor/endorphin System |
46 |
11 |
1Z01DA000398-06 |
SHIPPENBERG, TONI |
Neurochemical Interactions And Behavior In Drug Abuse |
47 |
11 |
5P50DA006634-100005 |
SMITH, JAMES |
DRUG REINFORCEMENT MECHANISMS |
48 |
11 |
5R01DA003628-16 |
SMITH, JAMES |
NEUROBIOLOGICAL PARAMETERS OF COCAINE REINFORCEMENT |
49 |
11 |
1Z01NS002139-27 |
WALTERS, JUDITH |
Pharmacology And Physiology Of The Substantia Nigra And |
50 |
11 |
5R01DA007348-10 |
WEISS, FRIEDBERT |
NOVEL TREATMENTS FOR COCAINE DEPENDENCE |
51 |
11 |
5K05DA000456-02 |
WHITE, FRANCIS |
COCAINE ADDICTION AND NEURONAL EXCITABILITY |
52 |
11 |
5K08GM000681-03 |
WHITTINGTON, ROBERT |
ANESTHESIA AND COCAINE INDUCED CNS EXCITOTOXICITY |
53 |
11 |
1P01DA013367-01A10001 |
WILKINS, DIANA |
TOLERANCE INDUCTION |
54 |
11 |
1Z01DA000445-01 |
WISE, ROY |
Brain Temperature, Reward, And Drugs Of Abuse |
55 |
11 |
5R37DA004216-13 |
ZAHNISER, NANCY |
COCAINE SENSITIZATION AND THE DOPAMINE TRANSPORTER |
56 |
8 |
5F31DA005939-03 |
BYRNES-BLAKE, KELLY |
ANTIBODY BASED THERAPY FOR CHRONIC METHAMPHETAMINE USE |
57 |
8 |
1R03AA012903-01A1 |
DUVAUCHELLE, CHRISTINE |
Behavioral Methodology Facilitating Ethanol Reward |
58 |
8 |
5R01DA013780-02 |
LANDRY, CHARLES |
GENE EXPRESSION PROFILE IN RESPONSE TO DRUG PAIRED CUES |
59 |
8 |
1Z01MH002623-11 |
LEE, KAN |
Radioligand Discovery And Development |
60 |
8 |
5R01AA010567-06 |
RASMUSSEN, DENNIS |
ALCOHOL EFFECTS ON OPIOMELANOCORTINERGIC REGULATION |
61 |
8 |
5K02DA000184-08 |
SCHENK, JAMES |
DRUGS OF ABUSE AND DOPAMINE RELEASE AND REUPTAKE |
62 |
8 |
1P01DA013367-01A10004 |
WHITE, HENRY |
SEIZURE INDUCTION |
63 |
5 |
5R01DA011504-04 |
ABEL, MARC |
COCAINE INDUCED BEHAVIORAL SENSITIZATION AND SEIZURES |
64 |
5 |
1U01AA013497-01 |
ALCANTARA, ADRIANA |
Ethanol Driven Neuroadaptation/Cholinergic Interneurons |
|
|
|
|
|
65 |
5 |
1F31DA006095-01 |
ALLEWEIRELDT, ANDREA |
DOPAMINE D1 RECEPTORS AND COCAINE-SEEKING BEHAVIOR |
66 |
5 |
5R01AA008674-10 |
ALTURA, BURTON |
BASIS FOR ALCOHOL AND COCAINE STROKES--ROLE OF MG2+ |
67 |
5 |
5R37DA007595-10 |
AMARA, SUSAN |
MOLECULAR STUDIES OF CATECHOLAMINE TRANSPORTERS |
68 |
5 |
5S06GM060654-020001 |
ANGULO, JESUS |
MECHANISM OF SENSITIZATION TO COCAINE |
69 |
5 |
3S06GM060654-02S10001 |
ANGULO, JESUS |
MECHANISM OF SENSITIZATION TO COCAINE |
70 |
5 |
3S06GM060654-02S20001 |
ANGULO, JESUS |
MECHANISM OF SENSITIZATION TO COCAINE |
71 |
5 |
5F32DA006074-02 |
BAKER, DAVID |
COCAINE INDUCED ALTERATIONS GLUTAMATE NEUROTRANSMISSION |
72 |
5 |
5U19DA012043-040001 |
BALL, WILLIAM |
ANTIBODY CHARACTERIZATION |
73 |
5 |
5R01DA001442-24 |
BALSTER, ROBERT |
THE BEHAVIORAL PHARMACOLOGY OF PHENCYCLIDINE |
74 |
5 |
5R01DA006470-10 |
BANNON, MICHAEL |
COCAINE BINDING DOPAMINE TRANSPORTER--MOLECULAR BIOLOGY |
75 |
5 |
5R24MH047181-100015 |
BANNON, MICHAEL |
Analysis of Human Dopamine Transporter Gene Promoter |
76 |
5 |
5P50DA000266-300013 |
BARABAN, JAY |
PSYCHOTROPIC DRUG RESPONSIVE TRANSCRIPTION FACTORS |
77 |
5 |
1F30DA014205-01 |
BARI, AUSAF |
Role of TrkB and TrkC in Cocaine-Induced Sensitization |
78 |
5 |
5R25GM058268-040002 |
BAYORH, MOHAMED |
SEX DIFFERENCES IN CARDIOVASCULAR, HEMODYNAMIC, AND CELLULAR EFFECTS OF
COCAINE |
79 |
5 |
5R01DA012677-02 |
BECKER, JILL |
GENDER DIFFERENCES IN DRUG ABUSE |
80 |
5 |
3R01DA012677-02S1 |
BECKER, JILL |
GENDER DIFFERENCES IN DRUG ABUSE |
81 |
5 |
5R03DA012866-02 |
BEINFELD, MARGERY |
ACUTE AND CHRONIC COCAINE-INDUCED CCK RELEASE |
|
|
|
|
|
82 |
5 |
5P50DA006634-100010 |
BENNETT, BARBARA |
DOPAMINE TRANSPORTER MODIFICATIONS AND LONG ACTING TROPANES |
83 |
5 |
5R01DA003742-16 |
BIDLACK, JEAN |
PARTIAL OPIOIDS--POTENTIAL TREATMENTS FOR COCAINE ABUSE |
84 |
5 |
5R01MH058921-09 |
BLAKELY, RANDY |
ACUTE REGULATION OF NOREPINEPHRINE TRANSPORTERS |
85 |
5 |
5R01DA013137-02 |
BOOZE, ROSEMARIE |
HIV/COCAINE NEUROTOXICITY IN FEMALES |
86 |
5 |
5F31DA005931-02 |
BRANDON, CINDY |
VULNERABILITY TO RITALIN: ELECTOPHYSIOLOGY & BEHAVIOR |
87 |
5 |
3S06GM008168-19S20039 |
BRODERICK, PATRICIA |
NORMAL PSYCHOTIC COCAINE BEHAVIOR--NATURAL BASIS FOR CLOZAPINE |
88 |
5 |
5S06GM008168-210039 |
BRODERICK, PATRICIA |
NORMAL PSYCHOTIC COCAINE BEHAVIOR--NATURAL BASIS FOR CLOZAPINE |
89 |
5 |
1Z01OD010276-04 |
BUNGAY, PETER |
Microdialysis Studies |
90 |
5 |
5K01DA000285-05 |
BUNNEY, E |
ELECTROPHYSIOLOGY OF COCAINE, ETHANOL, AND COCAETHYLENE |
91 |
5 |
1R01DA014339-01 |
CARELLI, REGINA |
Neurophysiological Study: Cocaine & Natural Reinforcers |
92 |
5 |
1R21DA014962-01 |
CARELLI, REGINA |
Combined Voltammetry/Electrophysiology in Behaving Rats |
93 |
5 |
5R01DA011457-03 |
CAREY, ROBERT |
INTEROCEPTIVE DRUG CUE CONDITIONING OF COCAINE EFFECTS |
94 |
5 |
1R01DA012736-01A2 |
CARLEZON, WILLIAM |
BIOBEHAVIORAL MECHANISMS OF DRUG REWARD AND ADDICTION |
95 |
5 |
1R01MH063266-01 |
CARLEZON, WILLIAM |
Role of Nucleus Accumbens CREB in Depression |
96 |
5 |
1R21DA014789-01 |
CARLEZON, WILLIAM |
A Simple Behavioral Model of Cocaine Withdrawal in Rats |
97 |
5 |
2R01DA003240-18A2 |
CARROLL, MARILYN |
Vulnerability to Drug Abuse--Experimental Interventions |
98 |
5 |
3F30DA006024-01S1 |
CHAO, STEVEN |
DOPAMINE AND GLUTAMATE RECEPTOR INTERACTIONS |
99 |
5 |
5F30DA006024-02 |
CHAO, STEVEN |
DOPAMINE AND GLUTAMATE RECEPTOR INTERACTIONS |
100 |
5 |
5P50DA006634-100001 |
CHILDERS, STEVEN |
CHRONIC DRUG ACTIONS ON G PROTEIN COUPLED RECEPTOR MECHANISMS |
101 |
5 |
5R01DA009577-05 |
CORRIGALL, WILLIAM |
CHOLINERGIC AND OPIATE MECHANISMS IN DRUG REINFORCEMENT |
102 |
5 |
2K02DA000260-06 |
CUNNINGHAM, KATHRYN |
Neuropsychopharmacol Interactions - Cocaine & Serotonin |
103 |
5 |
5R01DA006511-10 |
CUNNINGHAM, KATHRYN |
NEUROBEHAVIORAL PHARMACOLOGY OF STIMULANTS |
104 |
5 |
3R01DA006511-10S1 |
CUNNINGHAM, KATHRYN |
NEUROBEHAVIORAL PHARMACOLOGY OF STIMULANTS |
105 |
5 |
2P01DA010044-069001 |
CZERNIK, ANDREW |
CORE B - SCIENTIFIC CORE |
106 |
5 |
5F31DA006044-02 |
DALLVECHIA-ADAMS, STEPHANIE |
CART PEPTIDE LOCALIZATION IN ACCUMBAL & NIGRAL PATHWAYS |
107 |
5 |
1R03DA015126-01 |
DE LA GARZA II, RICHARD |
Depression Enhances Vulnerability to Cocaine Relapse |
108 |
5 |
5P50DA006634-100003 |
DEADWYLER, SAMUEL |
NEUROPHYSIOLOGICAL ASSESSMENT OF COCAINE REINFORCEMENT |
109 |
5 |
5R01DA011486-04 |
DEADWYLER, SAMUEL |
NEUROPHYSIOLOGICAL ANALYSIS OF SELF ADMIN OF COCAINE |
|
|
|
|
|
110 |
5 |
5R01DA011541-03 |
DEUTSCH, HOWARD |
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE |
111 |
5 |
3R01DA011541-03S1 |
DEUTSCH, HOWARD |
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE |
112 |
5 |
3R01DA011541-03S2 |
DEUTSCH, HOWARD |
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE |
113 |
5 |
5R01DA012449-03 |
DUTTA, ALOKE |
DOPAMINE TRANSPORTER AGENTS AGAINST COCAINE DEPENDENCE |
114 |
5 |
5P01DA006284-120008 |
DWORKIN, STEVEN |
PILOT--INVOLVEMENT OF DELTA RECEPTORS IN REINFORCING EFFECT OF DRUGS |
115 |
5 |
5R01DA010327-05 |
ELLINWOOD, EVERETT |
PRESYNAPTIC DOPAMINE MECHANISMS AFTER CHRONIC COCAINE |
116 |
5 |
5R01DA012768-03 |
ELLINWOOD, EVERETT |
COCAINE WITHDRAWAL: A WINDOW OF TREATMENT OPPORTUNITY |
117 |
5 |
5P01DK056116-030001 |
ELMQUIST, JOEL |
FUNCTIONAL NEUROANATOMY OF LEPTIN RESPONSIVE NEURONS |
118 |
5 |
5R01DA005041-13 |
ETTENBERG, AARON |
MECHANISMS OF OPIATE AND STIMULANT DRUG REINFORCEMENT |
119 |
5 |
1R01DA013517-01A1 |
FERRIS, CRAIG |
MRI of Brain Function and Receptors in Cocaine Addiction |
120 |
5 |
1P01DA013367-01A10002 |
FLECKENSTEIN, ANNETTE |
Vmat AND NEUROTOXICITY |
121 |
5 |
5R01DA000869-26 |
FLECKENSTEIN, ANNETTE |
DRUG ABUSE AND REGULATORY ENZYMES OF BIOGENIC AMINES |
122 |
5 |
5R29DA011389-04 |
FLECKENSTEIN, ANNETTE |
METHAMPHETAMINE AND DOPAMINE TRANSPORTERS |
123 |
5 |
5K02DA000211-09 |
FRANCE, CHARLES |
BEHAVIORAL PHARMACOLOGY OF OPIOIDS |
124 |
5 |
5F32DA005950-03 |
FRANTZ, KYLE |
PERIADOLESCENT MDMA--LONG TERM NEUROBEHAVIORAL EFFECTS |
|
|
|
|
|
125 |
5 |
5F31DA006031-02 |
FRITZ, TAMMI |
CHARACTERIZATION OF CART PEPTIDES AND THEIR RECEPTORS |
126 |
5 |
1F31DA014857-01 |
GAFFANEY, JON |
Monitoring conformations within the dopamine transporter |
127 |
5 |
3P50CA084718-02S20004 |
GARCIA-DAVILA, MARTHA |
Pilot--Prenatal nicotine exposure and the dopaminergic system |
128 |
5 |
3P50CA084718-03S10004 |
GARCIA-DAVILA, MARTHA |
Pilot--Prenatal nicotine exposure and the dopaminergic system |
129 |
5 |
5P50CA084718-040004 |
GARCIA-DAVILA, MARTHA |
Pilot--Prenatal nicotine exposure and the dopaminergic system |
130 |
5 |
3P50CA084718-04S10004 |
GARCIA-DAVILA, MARTHA |
Pilot--Prenatal nicotine exposure and the dopaminergic system |
131 |
5 |
3R01DA011552-04S1 |
GATLEY, SAMUEL |
ESTIMATION OF SYNAPTIC DOPAMINE USING PET AND SPECT |
132 |
5 |
5R01DA003817-15 |
GLICK, STANLEY |
NEUROBEHAVIORAL MECHANISMS OF DRUG ADDICTION |
133 |
5 |
5R01DA006013-09 |
GOEDERS, NICHOLAS |
ENVIRONMENTAL INFLUENCES ON COCAINE SELF ADMINISTRATION |
134 |
5 |
1R01DA013463-01A1 |
GOEDERS, NICHOLAS |
Role for the HPA Axis in Methamphetamine Reinforcement |
135 |
5 |
1R03DA013647-01A1 |
GOEDERS, NICHOLAS |
Neurochemistry of Cocaine Reinforcement |
136 |
5 |
1Z01DA000001-17 |
GOLDBERG, STEVEN |
Control Of Behavior By Drug Injection |
137 |
5 |
1Z01DA000003-16 |
GOLDBERG, STEVEN |
Drugs On Learned and Spontaneous Behavior |
138 |
5 |
1Z01DA000240-09 |
GORELICK, DAVID |
New Treatment for Drug Dependence |
139 |
5 |
5F32DA005975-02 |
GREGG, TIMOTHY |
LONG ACTING TROPANE AND 3-ARYLINDAN COCAINE AGONISTS |
140 |
5 |
2R01NS008527-30 |
HESS, GEORGE |
CHEMICAL REACTIONS IN TRANSMISSION OF NERVE IMPULSES |
141 |
5 |
5P50AA003510-240026 |
HESSELBROCK, VICTOR |
PILOT STUDIES |
142 |
5 |
3P50AA003510-24S10026 |
HESSELBROCK, VICTOR |
PILOT STUDIES |
|
|
|
|
|
143 |
5 |
5K05DA000008-27 |
HOLTZMAN, STEPHEN |
BEHAVIORAL PHARMACOLOGY OF OPIOIDS |
144 |
5 |
3F30DA006058-01S1 |
HOTSENPILLER, GREGORY |
GLUTAMATE AND COCAINE CONDITIONED LOCOMOTION |
145 |
5 |
5F30DA006058-02 |
HOTSENPILLER, GREGORY |
GLUTAMATE AND COCAINE CONDITIONED LOCOMOTION |
146 |
5 |
3F31DA005799-03S1 |
HOUSHYAR, HANI |
NEUROSTEROIDS AND STRESS AND SELF ADMINISTRATION |
147 |
5 |
5R24DA007970-090001 |
HUANG, TIEN |
ANTI-PCP AGENTS FOR AIDS AND DRUG ABUSE |
148 |
5 |
5R01DA011960-04 |
IZENWASSER, SARI |
K OPIOIDS AND DOPAMINE--MECHANISMS OF STIMULANT ABUSE |
149 |
5 |
1R21DA013936-01A1 |
IZENWASSER, SARI |
Behavioral consequences of drug exposure in adolescents |
150 |
5 |
3R01DA008590-07S1 |
JANDA, KIM |
IMMUNOPHARMACOTHERAPY AS A TREATMENT FOR COCAINE ABUSE |
151 |
5 |
5U54NS039408-030003 |
JIMENEZ-RIVERA, CARLOS |
Noradrenergic modualtion of Glutamate Transmission in Prefrontal
Cortex--Cocaine |
152 |
5 |
5R01DA002073-21 |
JOHNSON, KENNETH |
NEUROCHEMICAL PHARMACOLOGY OF PHENCYCLIDINE |
|
|
|
|
|
153 |
5 |
5R01DA012513-02 |
KALIVAS, PETER |
GLUTAMATE AND CRAVING FOR COCAINE |
154 |
5 |
5R37DA003906-18 |
KALIVAS, PETER |
COCAINE OPIOIDS AND DRUG ABUSE |
155 |
5 |
5R01DA011716-04 |
KANTAK, KATHLEEN |
COGNITIVE ASPECTS OF ADDICTION-RELATED BEHAVIOR |
156 |
5 |
3R01DA011716-04S1 |
KANTAK, KATHLEEN |
COGNITIVE ASPECTS OF ADDICTION-RELATED BEHAVIOR |
157 |
5 |
3R01DA011716-04S2 |
KANTAK, KATHLEEN |
COGNITIVE ASPECTS OF ADDICTION-RELATED BEHAVIOR |
158 |
5 |
5R01DA011289-05 |
KAUER, JULIE |
GLUTAMATE SYNAPSES IN SENSITIZATION TO DRUGS OF ABUSE |
159 |
5 |
1F31DA014157-01A1 |
KEARNS, DAVID |
Compulsive Drug-Related Behavior/Classical Condition |
160 |
5 |
1P01DA013367-01A10003 |
KEEFE, KRISTEN |
NEUROPEPTIDES AND NEUROTOXICITY |
161 |
5 |
1R03DA015202-01 |
KHROYAN, TALINE |
Nicotine Self Administration in Mice |
162 |
5 |
5R01DA010468-06 |
KING, GEORGE |
PARAMETERS AND MECHANISMS OF COCAINE TOLERANCE |
163 |
5 |
1R01DA014024-01A1 |
KIRSTEIN, CHERYL |
Effects of Cocaine on the Developing Nucleus Accumbens |
164 |
5 |
5R01DA005180-10 |
KNUEPFER, MARK |
CARDIOVASCULAR EFFECTS OF COCAINE |
165 |
5 |
1R01DA013256-01A1 |
KNUEPFER, MARK |
Sympathetic Regulation of Endotoxemia in Drug Abuse |
166 |
5 |
5R24DA007970-090008 |
KOMISKEY, HAROLD |
LONG ACTING ANTICOCAINE THEAPY |
167 |
5 |
5R01DA007134-12 |
KONRADI, CHRISTINE |
PSYCHOSTIMULANT REGULATION OF NEURAL GENE EXPRESSION |
168 |
5 |
5P01DK026741-220004 |
KOOB, GEORGE |
BEHAVIORAL SIGNIFICANCE OF NEUROENDOCRINE PEPTIDES |
169 |
5 |
5R01DA004398-15 |
KOOB, GEORGE |
NEURONAL SUBSTRATES OF COCAINE REWARD |
170 |
5 |
5R01DA010072-05 |
KOOB, GEORGE |
DOPAMINE PARTIAL AGONISTS AND PSYCHOSTIMULANT DEPENDENCE |
|
|
|
|
|
171 |
5 |
5P01DA009467-080005 |
KOSOFSKY, BARRY |
Functional Brain Mapping of Cocaine Action |
172 |
5 |
5R01DA011548-05 |
KOZIKOWSKI, ALAN |
BIOLOGICAL STUDIES OF PIPERIDINE ANALOGS OF COCAINE |
173 |
5 |
5K05DA000049-24 |
KREEK, MARY |
ADDICTIVE DRUGS--PHARMACOLOGY AND PHYSIOLOGY |
174 |
5 |
5K05DA000418-03 |
KUHAR, MICHAEL |
MECHANISMS OF DRUGS OF ABUSE |
175 |
5 |
2R01DA010732-04A1 |
KUHAR, MICHAEL |
CART:A novel cocaine regulated neurochemical |
176 |
5 |
5R01DA009079-07 |
KUHN, CYNTHIA |
GENDER DIFFERENCES IN STIMULANT ACTION |
|
|
|
|
|
177 |
5 |
1R03TW001494-01 |
LECHAN, RONALD |
CART AND THE HYPOTHALAMIC-PITUITARY-THYROID AXIS |
178 |
5 |
5R01DA006519-10 |
LEE, TONG |
DOPAMINE PRESYNAPTIC INHIBITION AND COCAINE TREATMENT |
179 |
5 |
1F31DA014435-01 |
LICATA, STEPHANIE |
Role of Calcium in Cocaine-Induced Sensitization |
180 |
5 |
5F31DA005944-03 |
LOFTIS, JENNIFER |
COCAINE EFFECTS ON NMDA RECEPTOR/PROTEIN INTERACTIONS |
181 |
5 |
3P60DA005186-14S10005 |
LUCKI, IRWIN |
NEUROCHEMISTRY OF COCAINE DEPENDENCEE |
182 |
5 |
5P60DA005186-150005 |
LUCKI, IRWIN |
NEUROCHEMISTRY OF COCAINE DEPENDENCEE |
183 |
5 |
5K01DA000411-03 |
LUTFY, KABIRULLAH |
ORPHANIN FQ AND COCAINE SENSITIZATION |
184 |
5 |
5R01DA009160-06 |
MACTUTUS, CHARLES |
DEVELOPMENTAL NEUROTOXICITY OF COCAINE--AN IV RAT MODEL |
185 |
5 |
1R01DA013159-01A1 |
MAIER, STEVEN |
STRESSOR CONTROLLABILITY, DRUGS OF ABUSE, AND SEROTONIN |
186 |
5 |
5R01DA011949-03 |
MAKRIYANNIS, ALEXANDROS |
DOPAMINE TRANSPORTER LIGANDS AS COCAINE MEDICATIONS |
187 |
5 |
5R01DA011454-04 |
MALCOLM, ROBERT |
AMLODIPINE TREATMENT FOR COCAINE DEPENDENCE |
188 |
5 |
5P20RR015565-020003 |
MALDONADO-VLAAR, CARMEN |
NEUROPEPTIDE CONTROL/GENE EXPRESSION IN COCAINE SEEKING |
189 |
5 |
5S06GM008102-300075 |
MALDONADO-VLAAR, CARMEN |
ACCUMBAL GLUTAMATE RECEPTORS IN COCAINE CONDITIONING |
190 |
5 |
5R01DA009264-06 |
MALENKA, ROBERT |
DRUGS OF ABUSE & SYNAPTIC PROCESSES IN DOPAMINE SYSTEMS |
191 |
5 |
1R01DA014639-01 |
MARK, GREGORY |
Central Cholinergic Involvement in Cocaine Addiction |
192 |
5 |
5R29DA011203-04 |
MARK, GREGORY |
NUCLEUS ACCUMBENS INVOLVEMENT IN COCAINE REINFORCEMENT |
193 |
5 |
5R01DA002396-20 |
MARTIN, BILLY |
INHALATION OF DRUGS OF ABUSE |
194 |
5 |
5F32DA005978-02 |
MCFARLAND, KRISTA |
RELAPSE TO COCAINE SEEKING BEHAVIOR |
195 |
5 |
5R01DA009256-06 |
MCGINTY, JACQUELINE |
REGULATION OF BRAIN GLUTAMATE/DOPAMINE INTERACTIONS |
196 |
5 |
1R21MH063123-01 |
MICHAEL, ADRIAN |
Innovations for In Vivo Neurochemical Analysis |
197 |
5 |
3R01DA002632-22S1 |
MICZEK, KLAUS |
PSYCHOMOTOR STIMULANTS AND AGGRESSION |
198 |
5 |
5R01DA002632-23 |
MICZEK, KLAUS |
PSYCHOMOTOR STIMULANTS AND AGGRESSION |
199 |
5 |
1R21DA014185-01 |
MIDDAUGH, LAWRENCE |
Cocaine Self Administration and Relapse in Mice:Gene del |
200 |
5 |
5R01DA011927-04 |
MIGNOT, EMMANUEL |
SLEEP HOMEOSTASIS AND STIMULANT DRUGS OF ABUSE |
201 |
5 |
1F32DA014735-01 |
MITCHELL, JENNIFER |
Metabotropic glutamate receptor function in cocaine |
202 |
5 |
5R01DA012460-02 |
NADER, MICHAEL |
DOPAMINE D2 RECEPTORS IN PRIMATE MODELS OF COCAINE ABUSE |
203 |
5 |
1R01DA013188-01A1 |
NATION, JACK |
HEAVY METALS AND POLYDRUG SELF-ADMINISTRATION |
204 |
5 |
2R01DA011064-05 |
NEISEWANDER, JANET |
NEURAL Mechanisms of Drug Seeking Behavior |
205 |
5 |
5K05DA000404-04 |
NESTLER, ERIC |
MOLECULAR STUDIES OF OPIATE AND COCAINE ACTION IN BRAIN |
206 |
5 |
5R01DA014133-02 |
NESTLER, ERIC |
NEUROTROPHIC FACTORS AND DRUGS OF ABUSE |
|
|
|
|
|
207 |
5 |
5R44DA013311-03 |
NEUMEYER, JOHN |
DOPAMINE AGONISTS FOR THE THERAPY OF COCAINE ADDICTION |
208 |
5 |
1R01HD039702-01A1 |
NOBLE, MARK |
CNS PRECURSOR CELL DYSFUNCTION IN DEVELOPMENTAL MALADIES |
209 |
5 |
5U19DA012043-040002 |
NORMAN, ANDREW |
PRE-CLINICAL ANIMAL TESTING |
210 |
5 |
1R01DA014020-01A1 |
O'DONNELL, PATRICIO |
Electrophysiology of Behavioral Sensitization |
|
|
|
|
|
211 |
5 |
1R03DA014552-01 |
ODUM, AMY |
Effects of Drugs in an Animal Model of Relapse |
212 |
5 |
1S06GM060314-01A10001 |
OJO, BABATUNDE |
Development of Cocaine Abuse Treatment Agents |
213 |
5 |
1F32DA014159-01 |
PECORARO, NORMAN |
Homeostatic Substrates of Incentive Re-Valuation |
214 |
5 |
5R01DA004600-13 |
PICKEL, VIRGINIA |
EM-TRANSMITTER INTERACTIONS OF STRIATAL OPIOID NEURONS |
215 |
5 |
5P50DA006634-100012 |
PORRINO, LINDA |
FUNCTIONAL SUBSTRATES OF COCAINE SELF ADMINISTRATION |
216 |
5 |
5P50DA006634-109006 |
PORRINO, LINDA |
CORE--ANIMAL |
217 |
5 |
1Z01MH002758-05 |
POST, ROBERT |
Pharmacology,Physiology Amygdala kindling&Quenching |
218 |
5 |
1Z01MH002759-05 |
POST, ROBERT |
Tolerance And Sensitization |
219 |
5 |
5R03DA013703-02 |
POTASHKIN, JUDITH |
COCAINE REGULATION OF FOSB SPLICING |
220 |
5 |
5R24DA012136-030004 |
QUINONES-JENAB, VANYA |
Estrous Cycle and Sex Differences in Cocaine-Induced Alterations in the
CNS |
221 |
5 |
5S06GM060654-020017 |
QUINONES-JENAB, VANYA |
STEROID AND COCAINE INTERACTIONS WITH CATECHOLAMINE SYSTEMS |
222 |
5 |
3S06GM060654-02S10017 |
QUINONES-JENAB, VANYA |
STEROID AND COCAINE INTERACTIONS WITH CATECHOLAMINE SYSTEMS |
223 |
5 |
3S06GM060654-02S20017 |
QUINONES-JENAB, VANYA |
STEROID AND COCAINE INTERACTIONS WITH CATECHOLAMINE SYSTEMS |
224 |
5 |
7K01DA014057-02 |
RAJADHYAKSHA, ANJALI |
Amphetamine-mediated CREB phosphorylation & gene express |
225 |
5 |
5K02DA000356-03 |
RAYPORT, STEPHEN |
PSYCHOSTIMULANT SENSITIZATION AT THE SYNAPTIC LEVEL |
226 |
5 |
1F30DA014238-01 |
REGINA, MEREDITH |
Hallucinogens--Serotonergic Glutamatergic Interactions |
227 |
5 |
1R03DA014063-01 |
RETI, IRVING |
Narp Expression and Drugs of Abuse |
228 |
5 |
5P50DA006634-100011 |
ROBERTS, DAVID |
NEUROBIOLOGY OF TROPANE ANALOG |
229 |
5 |
1R01DA014030-01 |
ROBERTS, DAVID |
A Novel Animal Model of Cocaine Addiction |
|
|
|
|
|
230 |
5 |
5K05DA000473-02 |
ROBINSON, TERRY |
NEUROPLASTIC ADAPTATIONS ENGENDERED BY DRUGS OF ABUSE |
231 |
5 |
2R01DA004294-14 |
ROBINSON, TERRY |
NEURAL BASIS OF BEHAVIORAL SENSITIZATION |
232 |
5 |
1R01DA013398-01A1 |
ROBINSON, TERRY |
Influence of drugs of abuse on neuronal morphology |
233 |
5 |
5P01DA009467-080006 |
ROSEN, BRUCE |
Structural Brain Mapping of Cocaine Action |
234 |
5 |
5R01DA013821-02 |
SANNA, PIETRO |
GENE EXPRESSION BASES OF COCAINE DEPENDENCE AND RELAPSE |
235 |
5 |
5K01DA000362-04 |
SCHROTT, LISA |
ABUSED DRUGS AND DEVELOPMENT OF THE NEUROIMMUNE AXIS |
236 |
5 |
5R01DA010462-05 |
SEE, RONALD |
BASOLATERAL AMYGDALA--A SUBSTRATE FOR RELAPSE |
237 |
5 |
3R01DA001568-23S1 |
SEGAL, DAVID |
BEHAVIORAL PHARMACOLOGY OF ACUTE AND CHRONIC AMPHETAMINE |
238 |
5 |
7R29DA010460-06 |
SELF, DAVID |
INTRACELLULAR MECHANISMS OF DRUG REWARD AND ADDICTION |
239 |
5 |
1Z01DA000434-02 |
SHAHAM, YAVIN |
Neurobiology Of Relapse To Heroin And Cocaine |
240 |
5 |
5R01DA012111-04 |
SINGHAL, PRAVIN |
HIV ASSOCIATED NEPHROPATHY IN DRUG ADDICTS |
241 |
5 |
1Z01MH000889-22 |
SMITH, CAROLYN |
Studies On Protein Synthesis And Amino Acid Compartmenta |
242 |
5 |
5K05DA000114-12 |
SMITH, JAMES |
NEUROBIOLOGICAL MECHANISMS OF DRUG REINFORCEMENT |
243 |
5 |
5R01DA012498-02 |
SMITH, JAMES |
NEUROBIOLOGY OF SPEEDBALL SELF-ADMINISTRATION |
|
|
|
|
|
244 |
5 |
5R03DA013000-02 |
SMITH, JAMES |
DRUG ABUSE & NEUROTRANSMITTER RECEPTOR AUTOANTIBODIES |
245 |
5 |
2P01DA010044-060001 |
SNYDER, GRETCHEN |
DRUGS OF ABUSE: ROLE OF Cdk5 IN THE ACTIONS OF PSYCHOSTIMULANTS |
246 |
5 |
5R01DA011787-03 |
SORG, BARBARA |
CORTICAL REGULATION OF SENSITIZATION |
247 |
5 |
3R01DA011787-03S1 |
SORG, BARBARA |
CORTICAL REGULATION OF SENSITIZATION |
248 |
5 |
1R21DA014915-01 |
SORG, BARBARA |
Cocaine and Brain Extracellular Matrix |
249 |
5 |
5P50DA005130-150010 |
SPANGLER, RUDOLPH |
DRUGS OF ABUSE & POTENTIAL THERAPEUTIC AGENTS--NEUROPEPTIDE MOLECULAR
EFFECTS |
250 |
5 |
5R29DA011261-04 |
STEINER, HEINZ |
OPIOID PEPTIDES AND COCAINE ABUSE |
251 |
5 |
1R01DA013470-01A1 |
STEKETEE, JEFFERY |
Medial Prefrontal Cortex and Cocaine Sensitization |
252 |
5 |
7R01DA013470-02 |
STEKETEE, JEFFERY |
Medial Prefrontal Cortex and Cocaine Sensitization |
253 |
5 |
3R01DA009750-06S1 |
STEWART, JANE |
NEUROBIOLOGY OF RELAPSE INDUCED BY STRESS AND DRUGS |
254 |
5 |
5R01DA012962-02 |
SUN, LENA |
CARDIOTOXICITY AFTER MATERNAL COCAINE EXPOSURE |
255 |
5 |
5F30DA006059-02 |
SZUCS, REGINA |
ROLE OF 5-HT2A RECEPTORS IN COCAINE-INDUCED BEHAVIOR |
256 |
5 |
1R41DA014774-01 |
TARAZI, FRANK |
Neuroadaptive effects after chronic CTDP 31446 treatment |
257 |
5 |
5R01DA011717-04 |
TAYLOR, JANE |
COGNITIVE DYSFUNCTION AFTER CHRONIC PCP, THC AND COCAINE |
258 |
5 |
3R41DA013521-01S1 |
TELLA, SRIHARI |
BEHAVIORAL STUDIES ON NOVEL MONOAMINE UPTAKE INHIBITORS |
259 |
5 |
7F32DA005945-04 |
THOMAS, MARK |
SYNAPTIC ACTIONS OF SEROTONIN IN THE NUCLEUS ACCUMBENS |
260 |
5 |
5R01DA011428-04 |
THOMAS, MARY |
COCAINE/SEX HORMONE/5HT--MOLECULAR & BEHAVIORAL ANALYSES |
|
|
|
|
|
261 |
5 |
5R01DA011528-05 |
TRUDELL, MARK |
SYNTHESIS OF POTENTIAL COCAINE ABUSE THERAPEUTICS |
262 |
5 |
1R21DA014189-01 |
TSIBULSKY, VLADIMIR |
Measurement of Priming and Satiety Thresholds in Mice |
263 |
5 |
5P50DA005130-150009 |
UNTERWALD, ELLEN |
DRUGS OF ABUSE AND POTENTIAL THERAPEUTIC AGENTS--EFFECT ON OPIATE
RECEPTORS |
264 |
5 |
5R01DA009580-06 |
UNTERWALD, ELLEN |
COCAINE INDUCED OPIOID, DOPAMINE AND BEHAVIORAL CHANGES |
265 |
5 |
1R01DA013669-01 |
VAN DE KAR, LOUIS |
TREATMENT OF COCAINE-INDUCED 5-HT DYSFUNCTION |
266 |
5 |
5R01DA005833-11 |
VATHY, ILONA |
OPIATES AND CNS DEVELOPMENT |
267 |
5 |
5R01DA006733-10 |
VORHEES, CHARLES |
DEVELOPMENTAL EFFECTS OF METHAMPHETAMINE LIKE STIMULANTS |
268 |
5 |
5P50DA006634-100008 |
VRANA, KENT |
EPIGENETIC IMPRINTING BY CHRONIC DRUGS OF ABUSE |
269 |
5 |
5R01DA013770-02 |
VRANA, KENT |
FUNCTIONAL GENOMICS OF COCAINE SELF ADMINISTRATION |
270 |
5 |
5R01GM035401-15 |
WANG, GING |
MOLECULAR BASIS OF LIGAND/SODIUM CHANNEL INTERACTIONS |
271 |
5 |
5R01DA008467-07 |
WEISS, FRIEDBERT |
NOVEL METHODS TO EXPLORE MECHANISMS OF COCAINE ABUSE |
272 |
5 |
5R01DA012180-03 |
WENTLAND, MARK |
AMINOBENZOMORPHAN: POTENTIAL COCAINE ABUSE MEDICATIONS |
273 |
5 |
3R01DA006886-09S1 |
WEST, MARK |
COCAINE SELF ADMINISTRATION MESOLIMBIC NEUROPHYSIOLOGY |
274 |
5 |
5F31DA005932-03 |
WHEELER, ROBERT |
DRUGS OF ABUSE, REWARD COMPARISON, AND SELECTED STRAINS |
275 |
5 |
3R01DA010900-04S1 |
WIGHTMAN, ROBERT |
DYNAMICS OF IN VIVO DOPAMINE RELEASE |
276 |
5 |
5R01DA004523-14 |
WILLIAMS, JOHN |
COCAINE--EFFECTS ON SINGLE NEURONS |
277 |
5 |
3R01DA004523-14S1 |
WILLIAMS, JOHN |
COCAINE--EFFECTS ON SINGLE NEURONS |
278 |
5 |
3R01DA004523-14S2 |
WILLIAMS, JOHN |
COCAINE--EFFECTS ON SINGLE NEURONS |
|
|
|
|
|
279 |
5 |
2R01DA003385-14A1 |
WINTER, JERROLD |
Behavioral & Pharmacological Analysis of Drugs of Abuse |
280 |
5 |
5R01DA004592-11 |
WOLGIN, DAVID |
INSTRUMENTAL LEARNING AND TOLERANCE TO STIMULANTS |
281 |
5 |
1R01DA013683-01 |
WOODS, JAMES |
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE |
282 |
5 |
2R01DA010352-06A1 |
WOOLVERTON, WILLIAM |
Dopaminergic Mechanisms in Stimulant Self Administration |
283 |
5 |
5P50DA005130-150004 |
YU, JUN |
DISPOSITION & BIOTRANSFORMATION OF NATURAL /SYNTHETIC OPIOID AGONISTS &
PEPTIDES |
284 |
5 |
5K02DA000174-10 |
ZAHNISER, NANCY |
PERSISTENT COCAINE INDUCED CHANGES IN DOPAMINE CLEARANCE |
285 |
5 |
5R01DA011480-04 |
ZHOU, RENPING |
EPH MOLECULES IN OTOGENY OF BRAIN REWARD CIRCUITS |
286 |
5 |
5P50DA005130-150011 |
ZHOU, YAN |
EFFECTS OF DRUGS OF ABUSE & POTENTIAL THERAPEUTIC AGENTS --EXPRESSION OF
HPA AXIS |